ARCHIVES

NCAB Rejects Automatic Loss Of Comprehensive Status For Center Without Core Grants

This article is from The Cancer Letter archive.

Vol. 04 No. 39 | September 29, 1978

Download PDF Visit The Full Archive

Related Articles

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

In Brief: Cooper Wouldn’t Take NIH Job, Says No One Has Asked Him To Take Top Health Spot

February 7, 1975

Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis

February 26, 2010

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

NCI Intramural Programs: Clinical Trials Support System Need Attention, report Advises DCS

December 19, 1997